Sundrug Co Ltd (SDGCF)
OTHER OTC:SDGCF
Holding SDGCF?
Track your performance easily

Sundrug Co (SDGCF) Financial Statements

7 Followers

Sundrug Co Financial Overview

Sundrug Co's market cap is currently ―. The company's EPS TTM is $1.693; its P/E ratio is 14.20; and it has a dividend yield of 3.36%. Sundrug Co is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 180.33B-¥ 166.46B¥ 157.07B¥ 164.91B
Gross Profit¥ 45.47B-¥ 40.01B¥ 37.88B¥ 40.27B
EBIT¥ 11.17B-¥ 9.16B¥ 6.75B¥ 9.62B
EBITDA¥ 11.17B-¥ 9.16B¥ 6.75B¥ 9.62B
Net Income Common Stockholders¥ 7.64B-¥ 6.30B¥ 4.85B¥ 6.55B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 84.83B¥ 0.00¥ 88.75B¥ 89.33B¥ 88.68B
Total Assets¥ 353.47B-¥ 326.25B¥ 325.77B¥ 321.88B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -84.83B¥ 0.00¥ -88.75B¥ -89.33B¥ -88.68B
Total Liabilities¥ 122.53B-¥ 103.56B¥ 105.18B¥ 106.11B
Stockholders Equity¥ 230.94B¥ 0.00¥ 222.69B¥ 220.59B¥ 215.77B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in JPY

Sundrug Co Earnings and Revenue History

Sundrug Co Debt to Assets

Sundrug Co Cash Flow

Sundrug Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis